Pituitary gland and β-catenin signaling: From ontogeny to oncogenesis

Pituitary

Volumn 12, Issue 3, 2009, Pages 245-255

  Gueorguiev, Maria ^a   Grossman, Ashley B ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

catenin; Pituitary tumor; Tumorigenesis

Indexed keywords

ALPHA CATENIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 4; BRG1 PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CASEIN KINASE I; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE; LYMPHOID ENHANCER FACTOR 1; MYC PROTEIN; PHOSPHODIESTERASE; PHOSPHOLIPASE C; PLAKOGLOBIN; PROTEIN BCL 2; PROTEIN KINASE C ALPHA; PROTEIN P300; RHO KINASE; SECRETED FRIZZLED RELATED PROTEIN 1; STEROIDOGENIC FACTOR 1; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR HESX1; TRANSCRIPTION FACTOR PIT 1; TRANSCRIPTION FACTOR PITX2; WNT PROTEIN; WNT4 PROTEIN; WNT5A PROTEIN;

CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL MATURATION; DOWN REGULATION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GONADOTROPIN SECRETING CELL; GROWTH HORMONE SECRETING CELL; HUMAN; HYPOPHYSIS ADENOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TSH SECRETING CELL; UPREGULATION;

ANIMALS; BETA CATENIN; HUMANS; MODELS, BIOLOGICAL; PITUITARY GLAND; PITUITARY NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 67849135776     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-008-0147-x     Document Type: Review

References (79)

1. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML et al (2004) The prevalence of pituitary adenomas: A systematic review. Cancer 101:613-619. doi: 10.1002/cncr.20412
2. Jagannathan J, Dumont AS, Prevedello DM, Lopes B, Oskouian RJ, Jane JA Jr et al (2005) Genetics of pituitary adenomas: Current theories and future implications. Neurosurg Focus 19:E4. doi: 10.3171/foc.2005.19.5.5
3. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91:4769-4775
4. Nielsen EH, Lindholm J, Laurberg P, Bjerre P, Christiansen JS, Hagen C, Juul S, Jørgensen J, Kruse A, Stochholm K (2007) Nonfunctioning pituitary adenoma: Incidence, causes of death and quality of life in relation to pituitary function. Pituitary 10:67-73
5. Asa SL, Ezzat S (2002) The pathogenesis of pituitary tumours. Nat Rev Cancer 2:836-849
6. Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29:22-32
7. Vergès B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C, Calender A (2002) Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 87:457-465
8. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Höfler H, Fend F, Graw J, Atkinson MJ (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 103:15558-15563
9. Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Mäkinen MJ, Tuppurainen K, Paschke R, Gimm O, Koch CA, Gündogdu S, Lucassen A, Tischkowitz M, Izatt L, Aylwin S, Bano G, Hodgson S, De Menis E, Launonen V, Vahteristo P, Aaltonen LA (2007) Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92:3321-3325
10. Boikos SA, Stratakis CA (2007) Carney complex: The first 20 years. Curr Opin Oncol 19:24-29
11. Bossis I, Voudetakis A, Matyakhina L, Pack S, Abu-Asab M, Bourdeau I, Griffin KJ, Courcoutsakis N, Stergiopoulos S, Batista D, Tsokos M, Stratakis CA (1996) A pleiomorphic GH pituitary adenoma from a Carney complex patient displays universal allelic loss at the protein kinase A regulatory subunit 1A (PRKARIA) locus. J Med Genet 41:596-600
12. Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP (1996) Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 97:699-705
13. Horvath A, Stratakis CA (2008) Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors. Rev Endocr Metab Disord 9:1-11
14. Hayward BE, Barlier A, Korbonits M, Grossman AB, Jacquet P, Enjalbert A, Bonthron DT (2001) Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 107:R31-R36
15. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gündogdu S, De Menis E, Mäkinen MJ, Launonen V, Karhu A, Aaltonen LA (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228-1230
16. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabaté MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Wémeau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montañana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A (2007) Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: Analysis in 73 families. J Clin Endocrinol Metab 92:1891-1896
17. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Wass JA, Popovic V, Ribeiro-Oliveira A Jr, Gadelha MR, Monson JP, Akker SA, Davis JR, Clayton RN, Yoshimoto K, Iwata T, Matsuno A, Eguchi K, Musat M, Flanagan D, Peters G, Bolger GB, Chapple JP, Frohman LA, Grossman AB, Korbonits M (2008) The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 93:2390-2401
18. Polakis P (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 17:45-51
19. He X, Semenov M, Tamai K, Zeng X (2004) LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: Arrows point the way. Development 131:1663-1677
20. Barker N, Hurlstone A, Musisi H, Miles A, Bienz M, Clevers H (2001) The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. EMBO J 20:4935-4943
21. Hecht A, Vleminckx K, Stemmler MP, van Roy F, Kemler R (2000) The p300/ CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J 19:1839-1850
22. Gordon MD, Nusse R (2006) Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429-22433
23. Kikuchi A, Kishida S, Yamamoto H (2006) Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med 38:1-10
24. Olson LE, Tollkuhn J, Scafoglio C, Krone A, Zhang J, Ohgi KA, Wu W, Taketo MM, Kemler R, Grosschedl R, Rose D, Li X, Rosenfeld MG (2006) Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. Cell 125:593-605
25. Strutt D (2003) Frizzled signalling and cell polarisation in Drosophila and vertebrates. Development 130:4501-4513
26. Mikels AJ, Nusse R (2006) Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4:e115
27. Kikuchi A, Yamamoto H, Kishida S (2007) Multiplicity of the interactions of Wnt proteins and their receptors. Cell Signal 19:659-671
28. Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH, Nusse R, Dawid IB, Nathans J (1999) A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398:431-436
29. Pauken CM, Capco DG (1999) Regulation of cell adhesion during embryonic compaction of mammalian embryos: Roles for PKC and beta-catenin. Mol Reprod Dev 54:135-144
30. Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483-1487
31. Ben Ze'ev A, Geiger B (1998) Differential molecular interactions of β-catenin and plakoglobin in adhesion, signalling and cancer. Curr Opin Cell Biol 10:629-639
32. Bierkamp C, Schwarz H, Huber O, Kemler R (1999) Desmosomal localization of β-catenin in the skin of plakoglobin null-mutant mice. Development 126:371-381
33. Kolligs FT, Kolligs B, Hajra M, Hu G, Tani M, Cho KR, Fearon ER (2000) Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin. Genes Dev 14:1319-1331
34. Chidgey M, Dawson C (2007) Desmosomes: A role in cancer? Br J Cancer 96:1783-1787
35. Simcha I, Shtutman M, Salomon D, Zhurinsky J, Sadot E, Geiger B, Ben Ze'ev A (1996) Differential nuclear translocation and transactivation potential of β-catenin and plakoglobin. J Cell Biol 133:199-209
36. Winn RA, Bremnes RM, Bemis L, Franklin WA, Miller YE, Cool C, Heasley LE (2002) Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 21:7497-7506
37. Katoh M, Katoh M (2006) Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther 5:1059-1064
38. Billottet C, Elkhatib N, Thiery JP, Jouanneau J (2004) Targets of fibroblast growth factor 1 (FGF-1) and FGF-2 signaling involved in the invasive and tumorigenic behavior of carcinoma cells. Mol Biol Cell 15:4725-4734
39. Cha KB, Douglas KR, Potok MA, Liang H, Jones SN, Camper SA (2004) WNT5A signaling affects pituitary gland shape. Mech Dev 121:183-194
40. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG (1998) Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12:1691-1704
41. Wang J, Shackleford GM (1996) Murine Wnt10a and Wnt10b: Cloning and expression in developing limbs, face and skin of embryos and in adults. Oncogene 13:1537-1544
42. Burrows HL, Douglas KR, Seasholtz AF, Camper SA (1999) Genealogy of the anterior pituitary gland: Tracing a family tree. Trends Endocrinol Metab 10:343-352
43. Gage PJ, Suh H, Camper SA (1999) Dosage requirement of Pitx2 for development of multiple organs. Development 126:4643-4651
44. Lin CR, Kioussi C, O'Connell S, Briata P, Szeto D, Liu F, Izpisua-Belmonte JC, Rosenfeld MG (1999) Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 401:279-282
45. Lu MF, Pressman C, Dyer R, Johnson RL, Martin JF (1999) Function of Rieger syndrome gene in left-right asymmetry and craniofacial development. Nature 401:276-278
46. Gage PJ, Roller ML, Saunders TL, Scarlett LM, Camper SA (1996) Anterior pituitary cells defective in the cell-autonomous factor, df, undergo cell lineage specification but not expansion. Development 122:151-160
47. Kioussi C, Briata P, Baek SH, Rose DW, Hamblet NS, Herman T, Ohgi KA, Lin C, Gleiberman A, Wang J, Brault V, Ruiz-Lozano P, Nguyen HD, Kemler R, Glass CK, Wynshaw-Boris A, Rosenfeld MG (2002) Identification of a Wnt/Dvl/beta-catenin--Pitx2 pathway mediating cell-type-specific proliferation during development. Cell 111:673-685
48. Baek SH, Kioussi C, Briata P, Wang D, Nguyen HD, Ohgi KA, Glass CK, Wynshaw-Boris A, Rose DW, Rosenfeld MG (2003) Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc Natl Acad Sci USA 100:3245-3250
49. Briata P, Ilengo C, Corte G, Moroni C, Rosenfeld MG, Chen CY, Gherzi R (2003) The Wnt/beta-catenin->Pitx2 pathway controls the turnover of Pitx2 and other unstable mRNAs. Mol Cell 12:1201-1211
50. Douglas KR, Brinkmeier ML, Kennell JA, Eswara P, Harrison TA, Patrianakos AI, Sprecher BS, Potok MA, Lyons RH Jr, MacDougald OA, Camper SA (2001) Identification of members of the Wnt signaling pathway in the embryonic pituitary gland. Mamm Genome 12:843-851
51. Salisbury TB, Binder AK, Nilson JH (2008) Welcoming {beta}-Catenin to the GnRH Transcriptional Network in Gonadotropes. Mol Endocrinol 22:1295-1303
52. Salisbury TB, Binder AK, Grammer JC, Nilson JH (2007) Maximal activity of the luteinizing hormone beta-subunit gene requires beta-catenin. Mol Endocrinol 21:963-971
53. Gardner S, Maudsley S, Millar RP, Pawson AJ (2007) Nuclear stabilization of (beta)-catenin and inactivation of glycogen synthase kinase-3(beta) by gonadotropin-releasing hormone: Targeting Wnt signaling in the pituitary gonadotrope. Mol Endocrinol 21:3028-3038
54. Kerr JM, Gordon DF, Woodmansee WW, Sarapura VD, Ridgway EC, Wood WM (2005) Growth arrest of thyrotropic tumors by thyroid hormone is correlated with novel changes in Wnt-10A. Mol Cell Endocrinol 238:57-67
55. Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM (2005) Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 65:10214-10222
56. Evans CO, Moreno CS, Zhan X, McCabe MT, Vertino PM, Desiderio DM, Oyesiku NM (2008) Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses. Pituitary 11:231-245
57. Ruebel KH, Leontovich AA, Jin L, Stilling GA, Zhang H, Qian X, Nakamura N, Scheithauer BW, Kovacs K, Lloyd RV (2006) Patterns of gene expression in pituitary adenomas and carcinomas analysed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression. Endocr 29:435-444
58. Semba S, Han SY, Ikeda H, Horii A (2001) Frequent nuclear accumulation of beta-catenin in pituitary adenoma. Cancer 91:42-48
59. Howng SL, Wu CH, Cheng TS, Sy WD, Li PC, Wang C, Hong YR (2002) Differential expression of Wnt genes, beta-catenin and E-cadherin in human brain tumors. Cancer Lett 183:95-101
60. Kremenevskaya N, Khattak MNK, Buchfelder M (2007) Activation of the Wnt 5A, β-catenin, TCF-4, cyclin D1 and E-cadherin in null cell pituitary adenomas. Proceedings of the 89th annual meeting of the endocrine society, P1-284, Abstract
61. Kremenevskaya N, Khan-Khattak MN, Schofl C, Buchfelder M (2008) Activation of the Wnt/β-catenin pathway in ACTH-secreting pituitary adenomas and inhibition through SRIH-14 in AtT-20 cells. Proceedings of the 90th annual meeting of the endocrine society, P3-510, Abstract
62. Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrubl F, Hahnen E, Kreutzer J, Fahlbusch R (2005) Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 109:589-597
63. Elston MS, Gill AJ, Conaglen JV, Clarkson A, Shaw JM, Law AJ, Cook RJ, Little NS, Clifton-Bligh RJ, Robinson BG, McDonald KL (2007) Wnt pathway inhibitors are strongly down-regulated in pituitary tumors. Endocrinology 149:1235-1242
64. Qian ZR, Li CC, Yamasaki H, Mizusawa N, Yoshimoto K, Yamada S, Tashiro T, Horiguchi H, Wakatsuki S, Hirokawa M, Sano T (2002) Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior. Mod Pathol 15:1357-1365
65. Tziortzioti V, Ruebel KH, Kuroki T, Jin L, Scheithauer BW, Lloyd RV (2001) Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues. Endocr Pathol 12:125-136
66. Xu B, Sano T, Yoshimoto K, Yamada S (2002) Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies. Endocr Pathol 13:341-351
67. Sano T, Rong QZ, Kagawa N, Yamada S (2004) Down-regulation of E-cadherin and catenins in human pituitary growth hormone-producing adenomas. Front Horm Res 32:127-132
68. Sun C, Yamato T, Kondo E, Furukawa T, Ikeda H, Horii A (2005) Infrequent mutation of APC, AXIN1, and GSK3B in human pituitary adenomas with abnormal accumulation of CTNNB1. J Neurooncol 73:131-134
69. Imai M, Nakamura T, Akiyama T, Horii A (2004) Infrequent somatic mutations of the ICAT gene in various human cancers with frequent 1p-LOH and/or abnormal nuclear accumulation of beta-catenin. Oncol Rep 12:1099-1103
70. Shi Y, He B, You L, Jablons DM (2007) Roles of secreted frizzled-related proteins in cancer. Acta Pharmacol Sin 28:1499-1504
71. Obari A, Sano T, Ohyama K, Kudo E, Qian ZR, Yoneda A, Rayhan N, Mustafizur Rahman M, Yamada S (2008) Clinicopathological features of growth hormone-producing pituitary adenomas: Difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 19:82-91
72. Ezzat S, Zheng L, Asa SL (2004) Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/ N-cadherin signaling to diminish cell adhesiveness: A mechanism underlying pituitary neoplasia. Mol Endocrinol 18:2543-2552
73. Ezzat S, Zheng L, Winer D, Asa SL (2006) Targeting N-cadherin through fibroblast growth factor receptor-4: Distinct pathogenetic and therapeutic implications. Mol Endocrinol 20:2965-2975
74. Qian ZR, Sano T, Yoshimoto K, Asa SL, Yamada S, Mizusawa N, Kudo E (2007) Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas. Mod Pathol 20:1269-1277
75. Pan H, Gao F, Papageorgis P, Abdolmaleky HM, Faller DV, Thiagalingam S (2007) Aberrant activation of β-catenin promotes genomic instability and oncogenic effects during tumor progression. Cancer Biol Ther 6:1638-1643
76. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:84-89
77. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142
78. Kikuchi A (2000) Regulation of beta-catenin signaling in the Wnt pathway. Biochem Biophys Res Commun 268:243-248
79. Musat M, Korbonits M, Kola B, Borboli N, Hanson MR, Nanzer AM, Grigson J, Jordan S, Morris DG, Gueorguiev M, Coculescu M, Basu S, Grossman AB (2005) Enhanced protein kinase B/Akt signalling in pituitary tumours. Endocr Relat Cancer 12:423-433